The Discounted Cash Flow (DCF) valuation of Biodesix, Inc. (BDSX) is (166.60) USD. With the latest stock price at 6.72 USD, the upside of Biodesix, Inc. based on DCF is -2579.1%.
Based on the latest price of 6.72 USD and our DCF valuation, Biodesix, Inc. (BDSX) is a sell. selling Biodesix, stocks now will result in a potential gain of 2579.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 9.9% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (670.60) - (98.72) | (166.60) |
| Upside | -10079.2% - -1569.1% | -2579.1% |